(PR1J) Amundi Prime Japan DR (D) - Ratings and Ratios
Japan Stocks, Large Cap Stocks, Equity Funds
Description: PR1J Amundi Prime Japan DR (D)
The Amundi Prime Japan UCITS ETF DR (D) is an exchange-traded fund (ETF) listed on XETRA, tracking the Morningstar Japan TME NR JPY index. As a Japan Large-Cap Blend Equity ETF, it provides diversified exposure to the Japanese equity market, focusing on large-cap stocks.
With Assets Under Management (AUM) of approximately €177.46 billion, this ETF is one of the larger players in the Japan Large-Cap Blend Equity category, suggesting a high level of investor confidence and liquidity. The funds size can contribute to lower expense ratios and tighter bid-ask spreads, making it an attractive option for investors seeking to gain exposure to the Japanese market.
To further evaluate the ETFs performance, key metrics such as tracking error, expense ratio, and dividend yield should be considered. A low tracking error would indicate that the ETF is effectively replicating the performance of its underlying index. The expense ratio, which represents the funds operating expenses as a percentage of its AUM, is crucial in assessing the cost-efficiency of the investment. Additionally, the dividend yield can provide insights into the income generated by the ETF, which is particularly relevant for income-focused investors.
From a quantitative perspective, analyzing the ETFs historical returns, Sharpe ratio, and beta can offer valuable insights into its risk-adjusted performance and volatility relative to the broader market. The Sharpe ratio, in particular, can help investors understand the ETFs excess returns relative to its risk, while the beta can provide insights into its systematic risk. By examining these KPIs, investors can make more informed decisions about the suitability of the Amundi Prime Japan UCITS ETF DR (D) for their investment portfolios.
Additional Sources for PR1J ETF
PR1J ETF Overview
Market Cap in USD | 202,798m |
Category | Japan Large-Cap Blend Equity |
TER | 0.05% |
IPO / Inception | 2019-01-30 |
PR1J ETF Ratings
Growth Rating | 55.1 |
Fundamental | - |
Dividend Rating | 56.1 |
Rel. Strength | -20.6 |
Analysts | - |
Fair Price Momentum | 25.90 EUR |
Fair Price DCF | - |
PR1J Dividends
Dividend Yield 12m | 1.91% |
Yield on Cost 5y | 2.89% |
Annual Growth 5y | 5.58% |
Payout Consistency | 97.7% |
Payout Ratio | % |
PR1J Growth Ratios
Growth Correlation 3m | -32% |
Growth Correlation 12m | 35.3% |
Growth Correlation 5y | 77.4% |
CAGR 5y | 8.70% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | -1.09 |
Alpha | -10.56 |
Beta | 0.789 |
Volatility | 17.90% |
Current Volume | 7.7k |
Average Volume 20d | 5.5k |
Stop Loss | 27.6 (-3%) |
As of July 31, 2025, the stock is trading at EUR 28.45 with a total of 7,710 shares traded.
Over the past week, the price has changed by -1.63%, over one month by +0.49%, over three months by +2.89% and over the past year by +3.90%.
Partly, yes. Based on ValueRay´s Analyses, Amundi Prime Japan DR (D) (XETRA:PR1J) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.05 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PR1J is around 25.90 EUR . This means that PR1J is currently overvalued and has a potential downside of -8.96%.
Amundi Prime Japan DR (D) has no consensus analysts rating.
According to our own proprietary Forecast Model, PR1J Amundi Prime Japan DR (D) will be worth about 30.7 in July 2026. The stock is currently trading at 28.45. This means that the stock has a potential upside of +7.73%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.7 | 7.7% |